mepolizumab · Medicine question

From what age is Nucala (mepolizumab) indicated as add-on treatment for severe refractory eosinophilic asthma?

Name: From what age is Nucala (mepolizumab) indicated as add-on treatment for severe refractory eosinophilic asthma?
Published: 2026-11-08T01:57:21.842Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Nucala (mepolizumab) is indicated as add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older.

Sources for this answer

Nucala 100 mg solution for injection in pre-filled penGlaxoSmithKline UK · emc · SmPC §4.1 Therapeutic Indications · Version 11Document updated 12 January 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about mepolizumab